LND in UTUC? Here is the take home messages from Dr. Hooman Djaladat talk #AUA24 USC Urology Amer. Urol. Assn.

A great debate on LND in #UTUC by Dr. Hooman Djaladat and Phillip Pierorazio moderated by Angie Smith Society of Urologic Oncology meeting at #AUA24 🙌always a pleasure to receive endorsement from your mentor!

Many factors influencing choice of diversion. Surgeon bias heavily weighs in the discussion. Discussing now at #AUA2024 045IC Urinary Diversion course. Many myths debunked!

Great discussion on the role of primary RPLND in stage I and low-volume metastatic GCT by Legend Sia Daneshmand, M.D. USC Urology #AUA24

Thrilled to present our exciting findings that will revolutionize the way to approach training for Robotic- RNU #AUA24 Dr. Hooman Djaladat Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 USC Urology Amer. Urol. Assn.

Congratulations to Sia Daneshmand, M.D. and team Muhannad Alsyouf Erika L. Wood, MD,MPH Leilei Xia for winning the best video presentation at #AUA24 on their work on EP-RPLND for testicular cancer. USC Urology Amer. Urol. Assn.

The first report on "Outpatient" Robotic PC-RPLND for testicular cancer presented at #AUA24 Desiree E Sanchez Farshad Sheybaee Moghaddam Surgery by Dr. Hooman Djaladat USC Urology!

Midline extraperitoneal #RPLND (primary or post chemo) reduces surgical morbidity, eliminates ileus with short hospital stay (contemporary 90% discharge POD #1) Saum Ghodoussipour Brian Hu Muhannad Alsyouf Sunil Patel MD Hamed Ahmadi MD DrBagrodia Rob Hamilton

LN involvement in UTUC post-NAC: ☞ Lymphovascular invasion is the only predictor ☞ ypN+: Higher distant metastasis rate & earlier mortality. ☞ 1-yr OS: pN0 & ypN0 94%, pN+ 72%, ypN+ 64% (p < 0.001) Dr. Hooman Djaladat Riccardo Autorino MD PhD Alireza Ghoreifi, MD #ROBUUST #AUA24

Thrilled to present at the great session led by Dr. Griebling (Tomas L. Griebling ), Brian Keith McNeil , and Dr. Lange on Health Equity & outcomes: 🎯 High Socioeconomic Deprivation ⬇ #UTUC Overall Survival 🎯 Insurance type🔗Follow-up Length Dr. Hooman Djaladat Jamal Nabhani USC Urology

Our paper will be accessible for free for 50 days through the link below provided by Journal of Urology! 🔗jurology.com/eprint/XIM2FT4… Amer. Urol. Assn. Jennifer Regala

ROBUUST consortium investigating decisional and prognostic impact of ureteroscopy in high-risk #UTUC. Great to have UAB Urology UAB Heersink School of Medicine in this international, multi-institutional collaborative! Published ahead of print in Urologic Oncology & available now: sciencedirect.com/science/articl…

Hugely grateful for the chance to work with the incredible Alireza Ghoreifi, MD and Runzhuo Ma these past 3 years. Your tireless dedication and hard work have truly paid off. I'll miss you both dearly as you embark on your next career chapter.

Our PUBMIC trial has been published in the June issue of Journal of Urology. It is featured on the cover page and highlighted as the Editor's Choice by Rob Siemens. Dr. Hooman Djaladat USC Urology 🔗auajournals.org/doi/10.1097/JU…

Our reply to the editorial on the PUBMIC trial paper published in Journal of Urology Dr. Hooman Djaladat

🥇Happy to see that our article is selected as the top article of the week by Journal of Urology ✌️ Dr. Hooman Djaladat Sia Daneshmand, M.D. Farshad Sheybaee Moghaddam Mihir Desai Anne Schuckman Dr. René Sotelo USC Urology Radiology of USC

#bluelightcystoscopy increases detection of bladder cancer in all races. Sanam Ladi Seyedian Alireza Ghoreifi, MD Badrinath Konety, MD, MBA Max Kates Sima Porten Gary Steinberg Mark Tyson Bladder Cancer Advocacy Network Photocure IBCG

Pts should rarely require opioids post radical orchiectomy. This study puts its use into perspective. Don’t open the external ring! Significantly reduces pain and does not impact high ligation of cord or oncologic principles.

🥇Top Article of the Month Journal of Urology A surgical trial is always difficult to accomplish. Kudos to Dr. Hooman Djaladat and the team for achieving this goal. USC Urology USC Radiomics Lab Radiology of USC

🔥Great work by Taseen Haque published in @WJUrol ▶️36 PSH repairs, median 2-yr FU ▶️47% recurrence ▶️No significant diff in recurrence when comparing surgical approaches or techniques 🔗link.springer.com/article/10.100… Farshad Sheybaee Moghaddam Dr. Hooman Djaladat USC Urology